Knowledge Distillery

Though SARS-CoV-2 primarily targets the respiratory system, patients and survivors can suffer neurological symptoms. Yet, an unbiased understanding of…

SARS-CoV-2 has undergone progressive change with variants conferring advantage rapidly becoming dominant lineages e.g. B.1.617. With apparent…

The objective of this retrospective cohort analysis was to evaluate the relation between diagnosis of COVID-19 with SARS-CoV-2 variant B.1.1.7 (also…

The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension exists that variants of concern (VOCs) may evade vaccine…

Coronavirus disease (COVID-19) has been associated with a large variety of neurologic disorders. However, the mechanisms underlying these neurologic…

The objective of this study was to explore the spectrum of skeletal muscle and nerve pathology of patients who died following SARS-CoV-2 infection and…

Limited information is available on incidence and outcomes of COVID-19 in patients with multiple sclerosis (MS). This study investigated the risks of…

This case-control study enrolled 58 COVID-19 positive and 62 COVID-19 negative patients, matched for age, gender and neurological admission causes,…

The B.1.617.2 (delta) variant of the SARS-CoV-2, the virus that causes Covid-19, has contributed to a surge in cases in India and has now been…

Because of concerns about thrombotic events after vaccination with ChAdOx1 nCoV-19 (Oxford–AstraZeneca), several European countries have recommended…

The impact of the COVID‐19 pandemic on PD patients is yet to be determined.

The authors conducted a longitudinal case-control 18F-FDG-PET study in patients diagnosed with COVID-19-related encephalopathy.